Where Care Meets People
Refractive-error detection and correction services do not reach people through one universal doorway. This chapter focuses on where testing and spectacle provision occur—schools, outreach, pharmacies, vision centres, health centres, and combined models—and uses that comparison to judge what each route makes easier or harder about continuity. The practical value of the comparison is not choosing a permanent winner; it is learning to ask whether a delivery setting can carry a person from an initial test to the next necessary handoff.
The main routes are different ways of entering the same pathway
The Cochrane review offers a useful map of the service landscape. It identified 175 studies, 146 records from eye-care organizations, and 81 records from organization websites—a total of 402 resources—describing refractive and optical service delivery between January 2002 and November 2022. Most of the reported services included an eye test, an assessment of whether spectacles were needed, and the provision of spectacles. The review also found that eye-care providers sometimes worked with nurses, doctors, or teachers.
The important point is not the size of the inventory by itself. The resources describe different places where a person can enter care and different arrangements for getting from one stage to the next. In community care, the reported approaches were school-based services, pharmacies, and outreach. In primary care, they included vision centres, health centres, and combinations of centres with door-to-door delivery. The categories overlap in purpose—bringing testing and correction closer to people—but they do not create the same practical conditions.
A school-based service places the encounter in a setting where children already spend time. Teachers may be trained to give vision tests, or eye-care workers may visit the school. Some programs use a van or bus equipped as an eye-test centre. If a child appears to need correction, spectacles may be prescribed, with follow-up or referral arranged. A school can therefore lower the distance between the service and the child, while also providing an existing social and organizational setting in which adults can notice whether spectacles are being used.
That proximity does not guarantee completion. A test at school may still require a separate dispensing visit, a family decision, payment, or a referral to another facility. The school may be a strong entry point and a weak endpoint. Its usefulness depends on what connects the initial encounter to the correction itself and on whether someone remains responsible after the visiting team leaves.
Outreach works differently. Providers travel into the community, for example to workplaces or homes, and may stay for only a short period. This makes the model particularly suited to people who live far from established services or who would not otherwise travel to them. It may also allow eye tests and spectacles to be offered together, including at no charge. But its temporary nature creates a continuity question: if a person needs clarification, adjustment, replacement, or a later check, where should they go once the outreach team has moved on?
Pharmacies appear in the Cochrane map as another community route, although only three resources in the review described them. Their presence matters conceptually because a pharmacy is already part of many people's everyday movement through a community. Yet a familiar location should not be confused with demonstrated quality or effectiveness. The review's inventory tells us that pharmacy-based delivery has been reported; it does not establish how accurately it assesses refractive need, how consistently it provides suitable spectacles, or how well it supports follow-up.
Vision centres are more permanent. The Cochrane summary describes them as eye-care clinics staffed by trained eye-care workers that carry out tests and provide spectacles. Patients usually pay for the spectacles, though vouchers may help with the cost. A permanent location can make repeat contact more feasible than a one-time visit. It may also offer a recognizable place for people who need to return. But permanence does not remove every barrier: a centre can still be distant, unaffordable, or difficult to use for people whose work, schooling, or family responsibilities make travel costly.
Health centres occupy a different position. They are healthcare facilities rather than dedicated eye-care clinics, and they usually provide eye tests and spectacles. Their advantage is integration with an existing primary-care setting. Their constraint is that refractive care may share staff, space, attention, and supplies with other health needs. The Cochrane review also describes a combined model in which vision or health centres are paired with door-to-door delivery. That arrangement makes the permanent site an anchor while adding a route to people who may not reach it independently.
These descriptions are not a menu of interchangeable features. They identify the first design decision: where will the service meet the population it is trying to serve? A school may be the natural place to reach children, an outreach team may be necessary for remote communities, and a vision centre may be valuable when repeated access matters. A combined approach may be sensible when a fixed site exists but does not reach everyone. The answer depends on the geography, population, staffing, payment arrangements, and referral relationships around the service—not on the label of the model alone.
The categories become useful only when attached to the care-chain question. If the objective is initial reach, a service that travels or uses a setting people already attend may have an advantage. If the objective includes repeat assessment or later contact, a permanent place or a clearly defined referral relationship may matter more. If the main obstacle is payment, a vision centre without an affordable dispensing route may leave the central bottleneck intact. These are conditional judgments about pathway design, not claims that one approach produces better outcomes everywhere.
Reach is not the same as continuity
The distinction between temporary and permanent care is easy to overstate. Outreach is not simply “good for reach,” and a centre is not simply “good for continuity.” Each model has to be judged by the whole chain it can support. A school visit can include a referral and follow-up arrangement; a vision centre can be unreachable for the people most in need. The relevant comparison is not the setting in isolation but the handoff it enables after the test.
Consider two hypothetical services for children. The first visits schools, tests students, provides prescriptions, and gives families a place to obtain spectacles. The second operates a permanent centre near the district, but families must travel there and pay unless they qualify for a voucher. The school service may reach more children at the beginning. The centre may make later visits easier for families who can reach and afford it. Neither scenario allows us to conclude which service creates more sustained wearing, because that would require evidence about completed referrals, spectacle acquisition, use, and follow-up. The example is useful precisely because it exposes the missing comparison.
People also enter the pathway through different roles. Teachers can help bring a service into the school and may participate in vision testing or motivation. Nurses and doctors can connect refractive care to broader health settings. Eye-care workers perform or support the specialized assessment and dispensing described in the review. Families often control travel, payment, consent, and the everyday environment in which a child uses spectacles. These roles are not interchangeable, and naming them clarifies where a handoff can be lost.
A service that depends on teachers to identify a problem but gives no clear route to an eye-care provider has an unfinished interface. A service that dispenses spectacles but does not make the payment pathway understandable may have reached the testing endpoint without reaching the access endpoint. A centre that can provide correction but has no visible connection to schools or households may offer continuity only to those who already know how to use it. These are reasoned implications of the delivery descriptions, not measured failure rates from the Cochrane review. The review does not tell us how often referrals are completed, how reliably centres maintain supplies, or which model produces the best sustained spectacle use.
The regional pattern in the evidence map adds context but not a ranking. In the WHO South-East Asia region, outreach and vision centres were most commonly reported. In the African region, school-based delivery and outreach were mainly reported. In the Americas, outreach was mostly reported. Very few approaches were reported in the WHO Eastern Mediterranean region. These differences may reflect geography, existing infrastructure, organizational priorities, or what has been documented. They do not prove that a model is inherently appropriate for everyone in a region.
That limitation is central. The Cochrane review gathered studies, organizational records, and website reports to describe what services exist and how they work. It found prominent gaps in evaluation, with few studies attempting to assess the effectiveness of the delivery approaches. A large number of reports can establish that a model has been used; it cannot, by itself, establish that the model is accurate, equitable, affordable over time, or successful at sustaining spectacle use.
Affordability illustrates why the handoff matters. The Cochrane summary says that patients at vision centres usually pay for spectacles, although vouchers may help. The Frontiers review discusses cost as a barrier in low- and middle-income settings and reports that free spectacles performed better than a prescription-only or prescription-plus-letter comparison for children's wearing compliance. Removing price can therefore open an important link in the pathway. But a payment solution still has to be joined to an assessment, a suitable correction, a dispensing route, and support after the person receives it. Free provision is not a substitute for the rest of the service.
The same caution applies to discussions of low-cost or ready-made spectacles. The Frontiers article mentions a resource-constrained adult trial in India as evidence that ready-made spectacles may be a viable option in some settings. That example is not a direct result of the included child trials, and it does not show that every ready-made or low-cost option is clinically interchangeable with every precisely assessed correction. It is better understood as a reminder that service design includes economic constraints, while clinical suitability and continuity still have to be established for the population in question.
A sensible choice of entry point therefore begins with questions rather than a slogan. Who is least likely to reach a fixed facility? Who can return if the first encounter does not complete the correction? Where will a prescription become spectacles, and who pays? Which person or organization owns the referral? Can families understand the next step? How will the program know whether the service reached only a test endpoint or also a wearing endpoint? These questions apply the care-chain model to a real setting without pretending that the available evidence has already answered them.
The Cochrane evidence map gives refractive-error services a geography: schools, homes, workplaces, pharmacies, centres, and health facilities can all be places where the pathway begins. It does not give us a universal route. The right lesson is more demanding. A program must choose an entry point that fits its population and then make the next handoff visible, affordable, and possible. Once that route has been chosen, the crucial question is what happens after the eye test—when assessment must become dispensing, referral, and a correction that someone can actually use.